Evaluation of Serum Adrenal Androgens Among Prepubertal and Pubertal Boys With Autism Spectrum Disorder
NCT05811507 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-04-13
Summary
Autism spectrum disorder (ASD) is a neurodevelopmental disorder of unclear etiology. There are theories depicting the importance of sex steroid hormones in autism, since the prevalence of the disorder is male-biased. What makes boys more vulnerable to achieve the diagnosis of autism remains unclear. One of the theories strengthens the importance of fetal organizational effect of testosterone on brain development. Baron Cohen with coworkers showed that elevated fetal levels of several androgens including testosterone were high in male-fetuses who later in postnatal life achieved the diagnosis of autism and fetal testosterone levels were positively correlated with autistic traits in general population.
Females with conditions of abnormal prenatal exposure to testosterone and its sex steroid precursors, such as congenital adrenal hyperplasia and polycystic ovary syndrome, were found to have higher rate of autistic traits as well as their children were of higher risk of developing autism. However, the exact mechanism by which these hormones influence the manifestation of autistic traits remains undiscovered. Another model explaining higher prevalence of ASD in males is a female protective model which suggests that multiple genetic factors contribute to the development of ASD and that higher threshold of genetic liability is required in females compared to males. Zhang et al. demonstrated genetic evidence of sex differences in ASD confirming female protective model, employing investigation of de novo mutations, common variants of ASD candidate genes and their co-expression in male and female brain.
During infancy: The Gonadotropin releasing hormone (GnRH) pulse generator is reactivated by 6 to 10 days after birth. This period, termed the mini puberty of infancy, was first described in the 1970s. During mini puberty, luteinizing hormone (LH) levels approximate pubertal concentrations, reaching a peak between 16 and 20 days of life. Serum testosterone levels rise in response to rising concentrations of LH, paralleling an increase in Leydig cell number and testicular testosterone concentrations. Serum testosterone levels peak from 1 to 3 months (210 ± 130 ng/dL or 7.28 ± 4.51 nmol/L on day of life 30) and decline by roughly 50% per month reaching prepubertal levels by 7 to 12 months of age. Dihydrotestosterone (DHT) concentrations parallel the rise in testosterone, reaching pubertal values during the early postnatal period.
During puberty: Testosterone is produced primarily by the testes, though a small amount is also made in the adrenal gland. Gonadarche refers to the onset of sex steroid production from the gonads and occurs in response to pulsatile production of GnRH from the hypothalamus, which in turn stimulates production of LH and Follicle stimulating hormone (FSH) from the pituitary gland. LH stimulates the Leydig cells to produce testosterone, whereas FSH stimulates the Sertoli cells to proliferate and initiate spermatogenesis.
Active androgens are synthesized via two alternative pathways. The first of them is known as the classic "frontdoor" pathway with pregnenolone serving as androgen precursor, which underwent a conversion to DHEA and subsequently to androstenediol. These metabolic steps are catalyzed by CYP17A1 (in the C17,20-lyase step) and (mostly adrenal) AKR1C3 enzyme, respectively. Dehydroepiandrosterone (DHEA) and androstenediol are readily sulfated by SULT2A1 in adrenal cortex and their sulfates serve as the stock pool for the production of active androgens of the adrenal origin as the production of androgens in early childhood of boys is limited to extra-gonadal tissues, such as adrenal, skin, etc. These sulfated primary androgens may be subsequently deconjugated and metabolized by HSD3B1 and HSD3B2 isoforms to androstenedione and Total testosterone (TST) and then to 5α/β-reduced 17-oxo- and 17β-androgens, respectively. In addition, the androstenedione may be readily converted to testosterone by adrenal AKR1C3. From the aforementioned substances, TST, 5α-dihydrotestosterone, and 11-oxo-testosterone are known as the most potent bioactive androgens. Besides the "frontdoor" pathway the dihydrotestosterone may be also formed by so called "backdoor" pathway. This pathway is based on a direct conversion of 5α/β-reduced pregnane steroids (C21) to their 5α/β-reduced androgen (C19) metabolites which is catalyzed by the same enzyme converting pregnenolone to DHEA (CYP17A1 in the C17,20-lyase step). These 5α/β-reduced androgen (C19) metabolites include also the most active androgen 5α-dihydrotestosterone. The "backdoor" pathway is crucial for androgen synthesis in marsupials but may also be active in various human steroid-related disorders.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
serum total testosterone, serum androsterone, serum androstenedione and serum dehydroepiandrosterone sulfate
Venous blood samples will be collected into sterile EDTA tubes around 10 am. Blood taken from controls will be collected at the same time. All samples will be delivered into the laboratory immediately after collection and centrifuged at 3000 × g, 4 °C for 10 min. Plasma samples were stored at -80 °C until the analysis using ELIZA
- DIAGNOSTIC_TEST
-
The Childhood Autism Rating Scale (CARS)
It is done by rating the child's behaviors from 1 to 4. 1 being normal for your child's age, 2 for mildly abnormal, 3 for moderately abnormal, and 4 as severely abnormal. Scores range from 15 to 60 with 30 being the cutoff rate for a diagnosis of mild autism. Scores 30-37 indicate mild to moderate autism, while scores between 38 and 60 are characterized as severe autism
- DIAGNOSTIC_TEST
-
DSM-5 Diagnostic Criteria for ASD
Persistent deficits in social communication and social interaction across multiple contexts. Restricted, repetitive patterns of behavior, interests, or activities. Symptoms must be present in the early developmental period, Symptoms cause clinically significant impairment in social, occupational, or other important areas of current functioning.These disturbances are not better explained by intellectual disability or global developmental delay.
- DIAGNOSTIC_TEST
-
Assesment of IQ: The Stanford-Binet V (Stanford-Binet Intelligence Scales):
IQ Score ranges for the Stanford-Binet: Low average: 80-89 Average: 90-109 High average: 110-119 High achiever: 120-129 Moderately gifted: 130-144 Highly gifted: 145-160+
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 6 Years
- Max Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-30
- Primary Completion
- 2024-04-30
- Completion
- 2024-04-30
Countries
- Egypt
Study Locations
More Related Trials
-
Effects of Metformin on Androgens and Other Steroid Hormones in Affected Subjects With Autism
NCT06762041 ·Status: NOT_YET_RECRUITING
-
Characterizing ASD Adult Population Asking for a Diagnosis
NCT04147988 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders
NCT06443320 ·Status: RECRUITING ·Phase: NA
-
Precise Objective Automated Assessment System of Autism Spectrum Disorder From an Existing Big Cohort
NCT04875481 ·Status: COMPLETED
-
Autism Clinical Risk Factors Investigation With Microbiome and Metabolome Profiling
NCT05849233 ·Status: UNKNOWN
-
The Role of Epigenetic Modifications in Autism Spectrum Disorder
NCT03152838 ·Status: UNKNOWN
-
Mentorship Program for Individuals With Autism Spectrum Disorder (ASD)
NCT05300295 ·Status: COMPLETED ·Phase: NA
-
Exploring Theatrical Expressive Tasks for Children With ASD
NCT06468072 ·Status: RECRUITING ·Phase: NA
-
A 12-Week Crossover Study to Assess the Efficacy, Safety and Tolerability of L1-79 in Subjects Aged 12-21 Years With Autism Spectrum Disorder
NCT05067582 ·Status: COMPLETED ·Phase: PHASE2
-
Urinary Steroid Metabolites in Autism
NCT01197131 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of AST-001 in ASD Children
NCT06333964 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Applied Group Training Given to Mothers With Children With Autism on Perceived Social Support, Depressive Symptoms and Self-compassion
NCT06862804 ·Status: COMPLETED ·Phase: NA
-
Comparison of DSM-IV-TR and DSM-5 for ASD
NCT02296502 ·Status: COMPLETED
-
Evaluation of Behavioural Psycho & Physiological Responses in People With ASD During a Blood Test in Routine Care Practice
NCT04638452 ·Status: RECRUITING ·Phase: NA
-
Efficacy Evaluation and Mechanism Study of Ketogenic Diet on Autism Spectrum Disorder in Children
NCT06348433 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy of Bumetanide in Children With Autism Spectrum Disorder Guided by Peripheral Blood Biomarkers and Machine Learning Models
NCT07005414 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Aquatic Training on Motor Function in Children With Autism Spectrum Disorder
NCT05123066 ·Status: COMPLETED ·Phase: NA
-
The Relationship Between Social Memory Disorders and Sleep Spindles in Children With Autism Spectrum Disorder
NCT06306378 ·Status: RECRUITING
-
Multicenter Validation Study on Autism Screening Using a Machine-assisted System
NCT07006948 ·Status: NOT_YET_RECRUITING
-
Efficacy of Training Programme to Reduce Stress
NCT02384486 ·Status: COMPLETED ·Phase: NA
-
MOTOR PROFICIENCY IN RELATION TO COGNITIVE FUNCTIONS AND SEVERITY IN CHILDREN WITH AUTISM SPECTRUM DISORDERS
NCT06889233 ·Status: COMPLETED
-
Observational Prospective Study on Behavioral Outcomes of Children With Autism Spectrum Disorder (ASD) in Comparison to Those Without Neurodevelopmental Diagnoses
NCT02707939 ·Status: UNKNOWN
-
Evaluation of the Effectiveness of Bian-Stone Therapy in Children With Autism Spectrum Disorder
NCT06998459 ·Status: COMPLETED ·Phase: NA
-
Explore the Impacts of One Session Theta Burst Stimulation Over Cerebellum in Adults With Autism Spectrum Disorder
NCT05578261 ·Status: UNKNOWN ·Phase: NA
-
Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?
NCT05373173 ·Status: COMPLETED ·Phase: NA